Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 2
2011 1
2012 1
2013 1
2014 2
2015 1
2016 1
2017 3
2018 4
2019 1
2020 5
2021 1
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for oleoylethanolamide weight loss
Your search for Oleylethanolamide weight loss retrieved no results
Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances exendin-4-mediated weight loss in obese mice.
Brown JD, McAnally D, Ayala JE, Burmeister MA, Morfa C, Smith L, Ayala JE. Brown JD, et al. Am J Physiol Regul Integr Comp Physiol. 2018 Oct 1;315(4):R595-R608. doi: 10.1152/ajpregu.00459.2017. Epub 2018 Jun 27. Am J Physiol Regul Integr Comp Physiol. 2018. PMID: 29949410 Free PMC article.
Long-acting glucagon-like peptide-1 (GLP-1) receptor (GLP-1R) agonists (GLP-1RA), such as exendin-4 (Ex4), promote weight loss. On the basis of a newly discovered interaction between GLP-1 and oleoylethanolamide (OEA), we tested whether OEA enhances GLP-1RA-m …
Long-acting glucagon-like peptide-1 (GLP-1) receptor (GLP-1R) agonists (GLP-1RA), such as exendin-4 (Ex4), promote weight loss …
Dietary adaptation for weight loss maintenance at Yale (DAWLY): Protocol and predictions for a randomized controlled trial.
Fang X, Davis X, Flack KD, Duncan C, Li F, White M, Grilo C, Small DM. Fang X, et al. Front Nutr. 2022 Jul 28;9:940064. doi: 10.3389/fnut.2022.940064. eCollection 2022. Front Nutr. 2022. PMID: 35967820 Free PMC article.
BACKGROUND: Current therapies for obesity treatment are effective at producing short-term weight loss, but weight loss maintenance remains a significant challenge. ...The study aims are to (1) determine if pre-intervention dietary fat intake moderates …
BACKGROUND: Current therapies for obesity treatment are effective at producing short-term weight loss, but weight lo …
Oleoylethanolamide: A fat ally in the fight against obesity.
Brown JD, Karimian Azari E, Ayala JE. Brown JD, et al. Physiol Behav. 2017 Jul 1;176:50-58. doi: 10.1016/j.physbeh.2017.02.034. Epub 2017 Feb 27. Physiol Behav. 2017. PMID: 28254531 Review.
There is a significant need to elucidate basic physiological mechanisms and therapies that address this global health care crisis. Oleoylethanolamide (OEA) is an endocannabinoid-like lipid that induces hypophagia and reduces fat mass in rodents. ...Limited study of OEA sup …
There is a significant need to elucidate basic physiological mechanisms and therapies that address this global health care crisis. Oleoyl …
Gut-brain crosstalk regulates craving for fatty food.
Raghow R. Raghow R. World J Diabetes. 2017 Dec 15;8(12):484-488. doi: 10.4239/wjd.v8.i12.484. World J Diabetes. 2017. PMID: 29290921 Free PMC article. Review.
Patients undergoing Roux-en-Y gastric bypass (RYGB) surgery elicit striking loss of body weight. Anatomical re-structuring of the gastrointestinal (GI) tract, leading to reduced caloric intake and changes in food preference, are thought to be the primary drivers of …
Patients undergoing Roux-en-Y gastric bypass (RYGB) surgery elicit striking loss of body weight. Anatomical re-structuring of …
Biological functions and metabolism of oleoylethanolamide.
Thabuis C, Tissot-Favre D, Bezelgues JB, Martin JC, Cruz-Hernandez C, Dionisi F, Destaillats F. Thabuis C, et al. Lipids. 2008 Oct;43(10):887-94. doi: 10.1007/s11745-008-3217-y. Epub 2008 Aug 13. Lipids. 2008. PMID: 18704536 Review.
The present review is focused on the metabolism and the emerging roles of oleoylethanolamide (OEA) with emphasis on its effects on food intake control and lipid metabolism. ...It has been demonstrated that OEA has beneficial effects on health by inducing food intake contro …
The present review is focused on the metabolism and the emerging roles of oleoylethanolamide (OEA) with emphasis on its effects on fo …
Endocannabinoid-related molecules predict the metabolic efficacy of GLP-1 receptor agonism in humans with obesity.
Matias I, Lehmann EW, Zizzari P, Byberg S, Cota D, Torekov SS, Quarta C. Matias I, et al. J Endocrinol Invest. 2023 Nov 4. doi: 10.1007/s40618-023-02228-8. Online ahead of print. J Endocrinol Invest. 2023. PMID: 37924474
Here, we tested whether GLP-1RA treatment affects circulating NAE levels and whether NAEs may predict the efficacy of GLP-1RA treatment in humans with obesity undergoing weight loss maintenance. MATERIALS AND METHODS: We profiled plasma levels of NAEs in participant …
Here, we tested whether GLP-1RA treatment affects circulating NAE levels and whether NAEs may predict the efficacy of GLP-1RA treatment in h …
Potential mechanisms underlying the effect of bariatric surgery on eating behaviour.
Zakeri R, Batterham RL. Zakeri R, et al. Curr Opin Endocrinol Diabetes Obes. 2018 Feb;25(1):3-11. doi: 10.1097/MED.0000000000000379. Curr Opin Endocrinol Diabetes Obes. 2018. PMID: 29120924 Review.
PURPOSE OF REVIEW: Reduced energy intake, resulting from favourable changes in eating behaviour, is the predominant driver of weight loss following bariatric surgery. Here we review the most recent studies examining the impact of Roux-en-Y gastric bypass (RYGB) and …
PURPOSE OF REVIEW: Reduced energy intake, resulting from favourable changes in eating behaviour, is the predominant driver of weight …
Sex differences in endocannabinoids during 3 years of Mediterranean diet intervention: Association with insulin resistance and weight loss in a population with metabolic syndrome.
Soldevila-Domenech N, Pastor A, Sala-Vila A, Lázaro I, Boronat A, Muñoz D, Castañer O, Fagundo B, Corella D, Fernández-Aranda F, Martínez-González MÁ, Salas-Salvadó J, Fitó M, de la Torre R. Soldevila-Domenech N, et al. Front Nutr. 2022 Dec 1;9:1076677. doi: 10.3389/fnut.2022.1076677. eCollection 2022. Front Nutr. 2022. PMID: 36532543 Free PMC article.
BACKGROUND: Excess circulating endocannabinoids (eCBs) and imbalanced N-acylethanolamines (NAEs) related eCBs abundance could influence dietary weight loss success. We aimed to examine sex differences in the impact of a 3-years Mediterranean diet (MedDiet) intervent …
BACKGROUND: Excess circulating endocannabinoids (eCBs) and imbalanced N-acylethanolamines (NAEs) related eCBs abundance could influence diet …
Effects of oleoylethanolamide supplementation on the expression of lipid metabolism-related genes and serum NRG4 levels in patients with non-alcoholic fatty liver disease: A randomized controlled trial.
Tutunchi H, Ebrahimi-Mameghani M, Hosseinzadeh-Attar MJ, Roshanravan N, Mobasseri M, Najafipour F, Naeini F, Naghshi S, Asghari S, Akbarzadeh M, Soleimanzadeh H, Ostadrahimi A. Tutunchi H, et al. Clin Nutr ESPEN. 2023 Dec;58:311-319. doi: 10.1016/j.clnesp.2023.10.013. Epub 2023 Oct 21. Clin Nutr ESPEN. 2023. PMID: 38057021 Clinical Trial.
BACKGROUND: This study investigated the effects of oleoylethanolamide (OEA) supplementation on the expression levels of SIRT1, AMPK, PGC-1alpha, PPAR-gamma, CEBP-alpha and CEBP-beta genes and serum neuregulin 4 (NRG4) levels in patients with non-alcoholic fatty liver disea …
BACKGROUND: This study investigated the effects of oleoylethanolamide (OEA) supplementation on the expression levels of SIRT1, AMPK, …
Oea Signaling Pathways and the Metabolic Benefits of Vertical Sleeve Gastrectomy.
Hutch CR, Trakimas DR, Roelofs K, Pressler J, Sorrell J, Cota D, Obici S, Sandoval DA. Hutch CR, et al. Ann Surg. 2020 Mar;271(3):509-518. doi: 10.1097/SLA.0000000000003093. Ann Surg. 2020. PMID: 30702457 Free PMC article.
OBJECTIVE: The aim of this study was to determine whether downstream [peroxisome proliferator-activated-receptor alpha (PPARalpha) and the G-protein coupled receptor, GPR119] and upstream (a fatty acid translocase, CD36) signaling targets of N-oleoylethanolamide (OEA) were …
OBJECTIVE: The aim of this study was to determine whether downstream [peroxisome proliferator-activated-receptor alpha (PPARalpha) and the G …
26 results